← Back to Search

Artificial Intelligence

AI Analysis of 3D Ultrasound for IVF Outcomes (AI in ART Trial)

N/A
Waitlist Available
Led By Nikica Zaninovic, PHD
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately 6- 8 weeks
Awards & highlights

AI in ART Trial Summary

This trial proposes using AI to predict best IVF/ART outcomes. 3D sonography images of the ovary would be used to objectively assess baseline ovarian reserve before treatment.

Who is the study for?
This trial is for patients undergoing ovarian stimulation treatments, including those aiming for fresh embryo transfer and cryopreservation of oocytes or embryos. Healthy male partners of female subjects who consent can also participate.Check my eligibility
What is being tested?
The study tests an AI tool that analyzes 3D ultrasound images to predict the best IVF/ART outcomes. It aims to create an automated system that reduces physician bias by objectively assessing baseline ovarian reserve at the start of ART cycles.See study design
What are the potential side effects?
Since this trial involves data analysis using AI without direct medical interventions, there are no typical side effects associated with drugs or surgical procedures.

AI in ART Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately 6- 8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 6- 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of baseline antral follicle count
Number of retrieved oocytes
Secondary outcome measures
Number of clinical intrauterine pregnancies IVF
Number of clinical intrauterine pregnancies OI
Number of mature oocytes
+1 more

AI in ART Trial Design

1Treatment groups
Experimental Treatment
Group I: 3D Ultrasound with AIExperimental Treatment1 Intervention
AI tool to assess antral follicle count using 3 D Ultrasound

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor
1,054 Previous Clinical Trials
1,312,528 Total Patients Enrolled
24 Trials studying Infertility
4,633 Patients Enrolled for Infertility
Nikica Zaninovic, PHDPrincipal InvestigatorWeill Medical College of Cornell University

Media Library

AI to analyze 3 D ultrasound (Artificial Intelligence) Clinical Trial Eligibility Overview. Trial Name: NCT04255615 — N/A
Infertility Research Study Groups: 3D Ultrasound with AI
Infertility Clinical Trial 2023: AI to analyze 3 D ultrasound Highlights & Side Effects. Trial Name: NCT04255615 — N/A
AI to analyze 3 D ultrasound (Artificial Intelligence) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04255615 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To whom does this research opportunity apply?

"Eligibility for this research requires individuals of ages 18 to 89 who have undergone in vitro fertilization. The total number of recruits is capped at 4000."

Answered by AI

What goals is the scientific team seeking to accomplish through this research?

"The primary objectives of this trial, monitored over a fortnightly duration, is to assess the number of antral follicles present at baseline. Secondary goals include quantifying clinical intrauterine pregnancies through ART cycles and determining the amount of multiple gestation resulting from OI cycles. Furthermore, mature oocyte assessment will be an integral part in validating efficacy outcomes."

Answered by AI

Are individuals under the age of fifty eligible for this clinical trial?

"As outlined in the inclusion criteria, only those between 18 and 89 may participate. For younger patients there are 13 studies while 42 involve older adults aged 65 or over."

Answered by AI

Are there vacancies available for this clinical trial?

"The data hosted on clinicaltrials.gov indicates that this medical trial is no longer recruiting patients, with its most recent update occurring on March 27th 2023 and the initial post dating back to February 12th 2020. However, there are 249 distinct studies actively seeking participants at this moment in time."

Answered by AI

Who else is applying?

What state do they live in?
North Carolina
What site did they apply to?
Weill Cornell Medicine
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

I’ve tried clomid,didn’t work IVF, FET transfer got canceled due to high progesterone. Need help.
PatientReceived 2+ prior treatments
Recent research and studies
clinicaltrials.govStudy
Use of Artificial Intelligence for Clinical Assessment of Assisted Reproductive Techniques and IVF Outcomes
2020. "Use of Artificial Intelligence for Clinical Assessment of Assisted Reproductive Techniques and IVF Outcomes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04255615.
All > Ivf > Infertility
~610 spots leftby Jan 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top